GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Seelos Therapeutics Inc (FRA:NXE0) » Definitions » Deferred Policy Acquisition Costs

Seelos Therapeutics (FRA:NXE0) Deferred Policy Acquisition Costs


View and export this data going back to . Start your Free Trial

What is Seelos Therapeutics Deferred Policy Acquisition Costs?

Deferred Policy Acquisition Costs only applies to banks and insurance companies.


Seelos Therapeutics (FRA:NXE0) Business Description

Industry
Traded in Other Exchanges
Address
300 Park Avenue, 2nd Floor, New York, NY, USA, 10022
Seelos Therapeutics Inc is a clinical-stage biotechnology company. The company is focused on developing products that address unmet needs in Central Nervous System (CNS) disorders and other rare disorders.